The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B

Sima Besharat1,2, Aezam Katoonizadeh1, Shirin Moossavi1

  • 1Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Journal of Medical Virology
|September 3, 2015
PubMed

Insights

Chronic hepatitis B patients show inverse association between hepatic Sortilin-1 (SORT1) gene expression and Hepatitis B surface antigen (HBsAg) levels. This suggests SORT1 may play a role in HBsAg particle formation during HBV infection.

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Hepatitis B virus (HBV) infection causes chronic liver disease, fibrosis, and cirrhosis globally.
  • Hepatitis B surface antigen (HBsAg) is a key marker in HBV infection, reflecting viral load.
  • Sortilin-1 (SORT1) is implicated in protein trafficking and degradation pathways.

Purpose of the Study:

  • To investigate the relationship between hepatic and serum HBsAg expression and hepatic SORT1 gene expression in chronic HBV patients.
  • To explore the potential role of SORT1 in the pathogenesis of chronic hepatitis B.

Main Methods:

  • Liver biopsies from 30 chronic hepatitis B patients were analyzed.
  • Hepatic HBsAg expression was assessed using immunohistochemistry.
  • Hepatic SORT1 gene expression was quantified using quantitative real-time PCR (qRT-PCR).

Main Results:

  • 90% of liver biopsies showed positive HBsAg staining.
  • A significant inverse association was found between hepatic HBsAg and SORT1 gene expression (β = -0.5, P = 0.042).
  • HBV DNA levels correlated with both hepatocyte and serum HBsAg titers, and ALT levels correlated with hepatic activity index.

Conclusions:

  • Hepatic SORT1 gene expression is inversely associated with hepatic HBsAg expression in chronic hepatitis B.
  • Sortilin-1 may be involved in the formation or regulation of Hepatitis B surface antigen particles.
  • Further research is warranted to elucidate the precise role of SORT1 in HBV pathogenesis.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
32
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42